论文信息 - Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer - 字舞流文

Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer

P. Laurent-Puig | V. Heinemann | A. Jung | D. Neureiter | F. Liébaert | F. Montestruc | S. Stintzing | M. Grisoni | R. Thiébaut | Y. Gaston-Mathé | Marie-Lise Grisoni